Clinical Trials Directory

Trials / Completed

CompletedNCT01120990

Hybrid Blood Pressure Monitor Validation

Validation of a Hybrid Blood Pressure Monitor to Replace the Mercury Standard for Validation Studies According to Modified Criteria of the European Society of Hypertension International Protocol 2010

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of Athens · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Accepted

Summary

Assessment of the accuracy of a Blood Pressure Measuring Device with a digital display-column, NISSEI DM 3000, according to an adaptation of the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults".

Detailed description

According to the "European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults", 33 patients have their blood pressure measured by two observers using parallel connected mercury sphygmomanometers, blinded from each other's result, and then by the supervisor using the tested device, NISSEI DM 3000. The measurements using the mercury sphygmomanometers are repeated 5 times and in between them, 4 measurements using the tested device take place. If the results of the comparison of these measurements according to the analysis required by the protocol, meet the required criteria, the device is regarded as "Pass", otherwise as "Fail". In this study, instead of consecutive, simultaneous measurements of the two mercury sphygmomanometers and tha tested device will be taking place. This will be so to exclude any inaccuracy due to blood pressure variability and because the tested device has a controllable deflation rate and allows simultaneous measurements with the mercury sphygmomanometers. In addition, the investigators will be performing 6 set of measurements instead of 4.

Conditions

Interventions

TypeNameDescription
OTHERBlood Pressure MeasurementAll patients have their blood pressure measured simultaneously by two observers using parallel connected mercury sphygmomanometers and by a supervisor using the tested device, NISSEI DM 3000. Six sets of measurements are performed.

Timeline

Start date
2010-04-01
Primary completion
2010-06-01
Completion
2010-07-01
First posted
2010-05-11
Last updated
2012-04-18
Results posted
2012-03-07

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01120990. Inclusion in this directory is not an endorsement.